# Relmada Therapeutics, Inc.: Form S-1/A, filed Feb 26, 2019

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: S-1/A
- Filed: 2019-02-26
- Accepted by EDGAR: Feb 26, 2019, 16:45 ET
- Period: not reported
- Accession: 0001213900-19-003153
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390019003153/fs12019a1_relmadatherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390019003153/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390019003153/fs12019a1_relmadatherap.htm

Filed Feb 26, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-003153. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
